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Reactive oxygen species regulate context-dependent
inhibition of NFAT5 target genes
Nam-Hoon Kim1,5, Bong-Ki Hong1,5, Soo Youn Choi2, Hyug Moo Kwon2, Chul-Soo Cho1,3,
Eugene C Yi4 and Wan-Uk Kim1,3
The activation of nuclear factor of activated T cells 5 (NFAT5), a well-known osmoprotective factor, can be induced by isotonic
stimuli, such as activated Toll-like receptors (TLRs). It is unclear, however, how NFAT5 discriminates between isotonic and
hypertonic stimuli. In this study we identified a novel context-dependent suppression of NFAT5 target gene expression in RAW
264.7 macrophages stimulated with lipopolysaccharide (LPS) or a high salt (NaCl) concentration. Although LPS and NaCl both
used NFAT5 as a core transcription factor, these stimuli mutually inhibited distinct sets of NFAT5 targets within the cells.
Although reactive oxygen species (ROS) are essential for this inhibition, the source of ROS differed depending on the context:
mitochondria for high salt and xanthine oxidase for TLRs. Specifically, the high salt-induced suppression of interleukin-6 (IL-6)
production was mediated through the ROS-induced inhibition of NFAT5 binding to the IL-6 promoter. The context-dependent
inhibition of NFAT5 target gene expression was also confirmed in mouse spleen and kidney tissues that were cotreated with
LPS and high salt. Taken together, our data suggest that ROS function as molecular sensors to discriminate between TLR
ligation and osmotic stimuli in RAW 264.7 macrophages, directing NFAT5 activity toward proinflammatory or hypertonic
responses in a context-dependent manner.
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INTRODUCTION
The nuclear factor of activated T cells (NFAT) family is a
group of five transcription factors (NFAT1–5).1 NFAT5 was
originally identified as a tonicity-regulated transcription factor
involved in cellular protection from hypertonic stress.1
Accordingly, NFAT5 is highly expressed in tissues that are con-
stantly exposed to osmotic stress, such as the kidney, intestinal
epithelium and epidermis.2,3 NFAT5 can also be activated
under isotonic conditions, mediating physiologic or pathologic
responses. For example, NFAT5 has a role in lymphocyte
proliferation and survival,4 and mediates myoblast migration
during skeletal muscle myogenesis.5 NFAT5 expression in bone
marrow-derived cells also enhances atherosclerosis and drives
macrophage migration.6 In addition, NFAT5-deficient mice
show a marked reduction in antibody-induced arthritis,
suggesting that NFAT5 has a key role in regulating
rheumatoid arthritis.7
To date, it remains unclear how the transcription factor
NFAT5 discriminates between isotonic and hypertonic stimuli,
thereby producing context-dependent functional and molecu-
lar responses. This uncertainty may primarily be due to
controversy surrounding the association between inflam-
mation and osmotic stress. Several researchers have proposed
that osmotic stress induced by a panoply of secreted proteins
and proteolytic enzymes is the major cause of NFAT5
activation and subsequent inflammation.8 In contrast, we
previously demonstrated that NFAT5 activity is increased by
tumor necrosis factor-a and IL-1b stimulation under isotonic
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conditions.7 In addition, NFAT5 has been shown to contribute
to innate immunity by activating gene expression in macro-
phages upon Toll-like receptor (TLR) ligation, independent of
hypertonicity.9 Thus, NFAT5 may be part of a regulatory
pathway that is distinct from the pathway induced by
hypertonicity. Little is known, however, about the nature of
this upstream signaling pathway under isotonic conditions or
the pathway’s association with inter- or extracellular pathways
under hypertonic conditions.
Despite the ubiquitous expression of NFAT5 in various
tissues, this factor’s mechanism of action as a transcription
factor is largely unknown. It has been proposed that most
transcription factors perform specific functions, depending on
the conditions under which the signaling pathway is acti-
vated.10 This context dependency is one of the major tools
used by eukaryotes to expand on the complexity of
transcriptional regulation through evolution.11 Molecular
components of eukaryotic cells have continuously evolved
toward multifunctionality through mutations and adaptations,
several of which associate the components with a distinct
signaling pathway.12 In these cases, the molecule will acquire a
new function according to the upstream and downstream
context of the signaling axis. The identification of the context
to which a specific factor belongs will allow for the better
selection of therapeutic targets and a greater understanding of
the pathophysiology of the disease.
In this study we investigated the functional interaction
between hypertonicity and TLR-induced NFAT5 signaling in
RAW 264.7 macrophages in which both hypertonicity and
inflammation were present. We found that a distinct source of
reactive oxygen species (ROS) is required for the expression of
NFAT5 target genes under hypertonic conditions compared
with the source required for innate immunity: mitochondria
under high-salt (NaCl) conditions and xanthine oxidase for
TLRs. We also demonstrated how genes that respond to
hypertonicity are affected by non-hypertonic inflammatory
stimuli (or vice versa) and gained insight into the process by
which NFAT5 achieves context-dependent activity. Collectively,
our data provide new information on the ways in which cells
acquire context dependency and display functional diversity.
MATERIALS AND METHODS
Reagents
The following antibodies were obtained from commercial sources:
anti-nuclear matrix protein p84 (NMP p84; Abcam, Cambridge, MA,
USA) and anti-a-tubulin (Sigma, St Louis, MO, USA). Anti-NFAT5
antibody was generated as previously described.13 Matrigel basement
membrane matrix and DCFH-DA (2’,7’-dichlorofluorescein diacetate)
were purchased from BD Biosciences (San Jose, CA, USA), and the
nuclear factor-kB reporter gene was obtained from Promega
(Madison, WI, USA). All other reagents were purchased from Sigma.
Cloning of the NFAT5 reporter and IL-6 promoter reporter
To analyze the transcriptional activity of NFAT5, an NFAT5 consensus
sequence with tandem repeats was transferred into the pEGFP-N1
vector (Clontech, Palo Alto, CA, USA) and the pDsRed-Express-N1
vector (Clontech), from which the cytomegalovirus promoter was
then removed by the AseI and BamHI restriction enzymes. To
construct a reporter system for the interleukin (IL-6) promoter,
mouse genomic DNA, encompassing base-pair positions 938 to
11 relative to the start codon of the IL-6 gene, was cloned by PCR
using the primers 50-attaatcttcaacaacatgaggactgc-30 and 50-ggatccgaatt
gactatcgttctt-30. The PCR product was subsequently subcloned into a
pGEM-T Easy Vector System (Promega). The AseI/BamHI fragment
containing the IL-6 promoter was then transferred to the pEGFP-N1
vector. Finally, the DNA fragment was confirmed by sequencing
(Cosmo Genetech, Seoul, Korea).
Generation of stable cell lines
RAW 264.7 macrophages were obtained from the American Type
Culture Collection (Manassas, VA, USA). The cells were maintained in
RPMI 1640 medium containing 10% fetal bovine serum in a
humidified incubator at 37 1C. To construct a stable cell line transfected
with the NFAT5 reporter gene, the cells were seeded to 50% confluence
in 12-well plates and then transfected with green fluorescent protein
(GFP)- or red fluorescent protein-fused NFAT5 reporter genes (5mg)
using Lipofectamine. After 3 days, the cells were reseeded to less than
20–25% confluence and were then selected by treatment with
125mgml1 geneticin (Invitrogen, Carlsbad, CA, USA) for 3 weeks.
Transfection rates were determined by fluorescence microscopy.
To produce NFAT5-deficient macrophages, RAW 264.7 macro-
phages were seeded to 20% confluence in 12-well plates and were then
transduced with NFAT5 short hairpin RNA-harboring lentiviral
particles (Santa Cruz Biotechnology, Santa Cruz, CA, USA) in the
presence of polybrene (5mgml1). Scrambled short hairpin RNA was
used as a control. After 3 days, the cells were seeded to less than 20–
25% confluence and selected by treatment with 5mgml1 puromycin
(Invitrogen) for 3 weeks. The level of knockdown was determined by
immunoblotting for NFAT5 or by inspecting for fluorescent cells
cotransfected with the GFP reporter by microscopy.
Flow cytometry
Analyses of reporter gene expression and ROS content in the
intracellular space were performed using a FACSCanto flow cytometer
(BD Biosciences, Heidelberg, Germany). Dead cells and debris were
eliminated before analysis by forward- and side-scatter parameters.
The fluorescence of the reporter gene and the presence of ROS were
detected using GFP and fluorescein isothiocyanate filters, respectively.
Changes in mean fluorescence intensity were determined using
FlowJo analysis software (Tree Star, Ashland, OR, USA).
Fractionation and immunoblotting
To detect changes in NFAT5, cells were fractionated into cytosol and
nuclei using hypo- and hypertonic lysis buffers, as previously
described.7 Each lysate was separated on an 8% polyacrylamide gel
containing SDS and then transferred to a nitrocellulose membrane.
The membrane was agitated in blocking buffer containing anti-
NFAT5, anti-NMP p84 and anti-a-tubulin antibodies overnight in a
cold room and visualized using an enhanced chemiluminescence
system. NMP p84 and a-tubulin were used as nuclear and cytosolic
markers, respectively.
RNA isolation and real-time PCR
Total RNA was extracted from cells using an RNeasy Kit
(Qiagen, Valencia, CA, USA). RNA samples from kidney tissues were
prepared by homogenization using TRIzol reagent (Invitrogen),
phenol–chloroform extraction and isopropanol precipitation. The
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RNA (1mg per reaction) was reverse-transcribed to yield first-strand
cDNA using reverse transcriptase (Takara, Shiga, Japan). To determine
mRNA expression levels, cDNA converted from 1mg of total RNA was
diluted to various concentrations. The diluted cDNA was mixed with
pairs of primers, including those primers for mouse aldose reductase
(AR; 50-agtgcgcattgctgagaactt-30 and 50-gtagctgagtagagtggccatgtc-30),
the betaine-g-amino-butyric acid transporter (BGT-1; 50-ctgggagaga
cgggttttgggtattacatc-30 and 50-ggaccccaggtcgtggat-30), the sodium-
dependent myo-inositol cotransporter (SMIT; 50-ccgggcgctctatgacct
ggg-30 and 50-caaacagagaggcaccaatcg-30), IL-6 (50-ttccatccagttgccttcttg-30
and 50-aggtctgttgggagtggtatc-30), and glyceraldehyde 3-phosphate
dehydrogenase (50-tgatgacatcaagaaggtggtgaa-30 and 50-tccttggaggccatg
taggccat-30), along with cDNA sequences and SYBR Green PCR
Master Mix (BD Biosciences), in a 20-ml total volume. The PCR
cycling conditions were as follows: 5min at 95 1C for 1 cycle, 30 s at
95 1C, and 1min at 60 1C for 45 cycles. Gene expression was calculated
by the comparative 2DDCt method after normalization to glycer-
aldehyde 3-phosphate dehydrogenase levels. The specificity of the
amplification reactions was confirmed by melting curve analysis.
Enzyme-linked immunosorbent assays
Levels of IL-6 and MCP-1 in the culture supernatant were determined
using an enzyme-linked immunosorbent assay kit (R&D Systems,
Minneapolis, MN, USA) according to the manufacturer’s instructions.
Chromatin immunoprecipitation assay
Chromatin immunoprecipitationexperiments were performed according
to the manufacturer’s recommendations (Millipore, Billerica, MA,
USA). Briefly, cultured macrophages were fixed with 1% form-
aldehyde. The nuclei were isolated using fractionation buffer and
sonicated three times on ice for 10 s to shear the DNA into 200–
1000bp fragments. A small aliquot (50ml) was stored as input DNA.
Chromatin-containing lysates were incubated with anti-NFAT5 anti-
body. DNA–protein immunocomplexes were precipitated with pro-
tein A agarose coated with salmon sperm DNA and then treated with
proteinase K. The DNA samples were extracted with phenol/chloro-
form and precipitated with an ethanol and glycogen solution. To
analyze NFAT5 enrichment within the IL-6 promoter, immunopreci-
pitated DNA samples were amplified by PCR using a primer pair for
the IL-6 promoter (50-agctttacgttctctttctcctta-30 and 50-aagtgactcag
cacttgagca-30), as described previously.9 The exon region of IL-6
(50-ttccatccagttgccttcttg-30 and 50-aggtctgttgggagtggtatc-30) was used
as a negative control. Immunoprecipitated DNA and input DNA
enrichments were subjected to 35 cycles of PCR (94 1C for 30 s, 55 1C
for 30 s and 72 1C for 30 s) in 25ml reaction mixtures. The PCR
products then underwent electrophoresis on a 2% agarose gel in Tris-
acetate-EDTA buffer and were visualized using SafeView reagent
(Applied Biological Materials, Vancouver, BC, Canada).
Matrigel plug reporter assay
In vivo transcriptional activity was measured using the Matrigel plug
reporter assay.14 Briefly, 8-week-old male BALB/c mice (Orient Bio,
Seongnam, Korea) were subcutaneously injected in the dorsal region
with 0.6ml of Matrigel (BD Biosciences) containing 1 107 RAW
264.7 cells stably transfected with an red fluorescent protein-NFAT5
reporter. After stimulation of the cells with lipopolysaccharide
(LPS) in vivo, the fluorescence intensity of each Matrigel complex
was measured using a Maestro 2 Imaging System (CRi, Woburn,
MA, USA). Images were normalized and analyzed using
Maestro software 2.8 (CRi). Red fluorescent protein activity was
quantified as the total photons per second per centimeter squared per
steradian ( 106 p s1 cm2 sr1).
Statistical analysis
The data are expressed as the mean±s.d. Comparisons between
groups were made using paired or unpaired Mann–Whitney U-tests.
P-values less than 0.05 were considered to be statistically significant.
RESULTS
Induction of NFAT5 activity by TLR compared with high
salt concentration in macrophages
Using an NFAT5-specific GFP reporter construct, we con-
firmed that TLR ligation by LPS or heat-inactivated Escherichia
coli was capable of inducing NFAT5-dependent reporter
activity in RAW 264.7 macrophages (Figure 1a). These findings
were consistent with the results of a previous report.9 As
hypertonicity is a well-known stimulus for NFAT5 activation,1
we tested whether TLR ligation affects high salt-induced
NFAT5 activation. When RAW 264.7 macrophages were
cotreated with LPS (or E. coli) and NaCl, additive increases
in NFAT5-dependent reporter activity were observed
(Figure 1a). Furthermore, cotreatment with LPS and NaCl
induced additive increases in the trafficking of NFAT5 from
the cytoplasm to the nucleus in macrophages (Figure 1b). In
accordance with the in vitro results, combined treatment
resulted in a modest additive increase in NFAT5-dependent
reporter activity in the in vivo Matrigel assay (Figure 1c).
Taken together, these results suggest that TLR ligation does not
suppress or sensitize high salt-induced NFAT5 expression or
reporter activity in macrophages.
It has been reported that under hyperosmolar conditions,
NFAT5 modulates nuclear factor-kB activity in renal tubular
epithelial cells.15 In our previous study, performed in RAW
264.7 cells, LPS did not increase tonicity-inducible genes,
including AR, BGT-1 and SMIT, in contrast to high salt
concentrations.16 Conversely, nitrite and IL-6 production were
not altered by NaCl but were strongly increased by LPS.16 This
finding suggests that the context-dependent activation of
NFAT5 target genes is a function of the type of stimulus. In
this study, NFAT5 short hairpin RNA did not affect nuclear
factor-kB-dependent reporter activity in RAW 264.7
macrophages activated by LPS, which was mitigated by high-
salt conditions (Figure 1d). These data, in conjunction with
the findings of previous studies,15,16 suggest that although both
LPS and NaCl utilize NFAT5 as a key transcription factor for
cell signaling, the downstream effects are propagated in
distinct ways, depending on the nature of the stimulus.
Inhibition of NFAT5 target genes by LPS or high salt
A recent study demonstrated that NFAT5 regulates TLR-
induced proinflammatory gene expression in macrophages,
including the expression of IL-6, cyclooxygenase 2 and induced
nitric oxide synthase, which is mediated by nuclear factor-kB
activation.9 We also have shown that IL-6 production is nearly
entirely dependent on NFAT5 activation following TLR
ligation in RAW 264.7 macrophages.16 In this study we
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investigated the possibility of a functional interaction between
LPS and hypertonicity-induced NFAT5 signaling by cotreating
with LPS and NaCl. As observed in Figure 2a, we first
confirmed the context-dependent activation of NFAT5 target
genes in RAW 264.7 macrophages after individual treatment
with NaCl or LPS. Interestingly, the expression of tonicity-
inducible genes that are specifically controlled by NFAT5,17
including AR, BGT-1 and SMIT, was blocked by the
pretreatment of macrophages with LPS (Figure 2a). Conver-
sely, pretreatment with high salt inhibited the LPS-induced
increase in IL-6 protein and mRNA expression (Figure 2b).
This result was reproduced when the cells were simultaneously
stimulated by LPS and NaCl (data not shown). Similarly, LPS-
induced IL-6 promoter activity was also partially blocked by
the cotreatment of cells with NaCl (Figure 2c). These results
demonstrate that although LPS and hypertonicity share
NFAT5 as a core transcription factor, these stimuli reciprocally
inhibit the expression of downstream target genes.
Mannitol is widely used in anesthesia, critical care medicine
and in cases of sepsis.18 Although this drug’s clinical effects
were originally attributed to the osmotic regulation of cells,
other mechanisms, including anti-inflammatory action,19 have
also been proposed. In this study we tested whether mannitol
induces NFAT5 activity and alters TLR-triggered IL-6
expression in macrophages. Similar to LPS stimulation,
mannitol treatment dose-dependently increased NFAT5-
dependent reporter activity in RAW 264.7 macrophages
(Figures 3a and b). Moreover, LPS-induced IL-6 production
was partially inhibited by cotreatment with mannitol in a
dose-dependent manner. Mannitol alone, however, did not
affect IL-6 expression (Figure 3c). Thus, similar to high salt
hyperosmolar mannitol increases NFAT5 activity and down-
regulates IL-6 production by macrophages costimulated with
LPS.
ROS regulate context-dependent inhibition of NFAT5 target
gene expression
To date, the point at which LPS- and hypertonicity-mediated
pathways diverge with respect to NFAT5 activation remains
unknown. In addition, the mechanism by which LPS and NaCl
reciprocally inhibit downstream targets is not well understood.
We have shown that ROS regulate NFAT5 target gene expres-
sion in RAW 264.7 macrophages.16 Thus, we investigated
whether ROS are involved in the context-dependent inhibition
of NFAT5 target gene expression. Consistent with previous
reports,20,21 significant amounts of ROS were generated by
RAW 264.7 macrophages that had been stimulated with either
LPS or NaCl (Figure 4a). The time kinetics under the two
Figure 1 NFAT5 differentially affects nuclear factor-kB (NF-kB) activity in macrophages in a stimulus-dependent manner. (a and b)
Additive effects of LPS and NaCl on NFAT5 activation. LPS (5mgml1) or heat-inactivated E. coli (3106CFUml1) were added to
RAW 264.7 cells for 24h in the presence or absence of NaCl (90mM). NFAT5-green fluorescent protein (GFP) activity and NFAT5
translocation were determined by flow cytometry and western blot analysis, respectively. The data on the right in a show the mean±s.d.
of three independent experiments. *Po0.01 versus LPS or heat-inactivated E. coli alone. (c) LPS- and high salt-induced increases in
NFAT5 reporter activity in vivo. Matrigel with RAW 264.7 macrophages stably transfected with NFAT5-red fluorescent protein (RFP)
reporter were subcutaneously implanted into mice. On day 9, LPS (10mgkg1) and hypertonic saline (11.3% HS, 25cckg1) were
injected intraperitoneally. Normal saline (0.9% NS, 25cckg1) was injected as a control. At 16h post injection, NFAT5-RFP activity in
the Matrigel was determined using the Maestro Imaging System. (d) Transcriptional activity of NF-kB in NFAT5-deficient macrophages
treated with LPS (5mgml1) or NaCl (90mM). An NF-kB reporter containing GFP was transiently transfected into cells, and GFP activity
representing NF-kB was determined by flow cytometry (left). The bar graph on the right represents the mean±s.d. of five independent
experiments. *Po0.05 versus control short hairpin RNA (shRNA)-transfected cells in the presence or absence of NaCl. The reduction in
NFAT5 expression was confirmed by western blot analysis (top panel).
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conditions were similar, although LPS produced a greater
quantity of ROS than did the high-salt condition (Figure 4a).
When the cells were simultaneously treated with LPS and
NaCl, ROS production was not suppressed (Figure 4b).
Interestingly, in contrast to the hypertonic condition,
allopurinol (a xanthine oxidase inhibitor) completely sup-
pressed NFAT5 activation by LPS (Figure 4c), suggesting that
xanthine oxidase is required for LPS-induced NFAT5 activa-
tion under nonhypertonic conditions. In the same cells, the
induction of NFAT5 activity by high NaCl was not decreased
by allopurinol (Figure 4c), indicating that xanthine oxidase
regulation of NFAT5 activity is context dependent. Moreover,
myxothiazol, which is an inhibitor of mitochondrial ROS,22
strongly inhibited high salt-induced SMIT mRNA expression
in RAW 264.7 macrophages but did not downregulate LPS-
induced IL-6 and nitric oxide synthase mRNA expression
(Figures 5a and b). These data suggest that sources of ROS that
mediate NFAT5-dependent increases in IL-6, AR and SMIT
expression differ depending on context: mitochondria for high
salt and xanthine oxidase for TLRs. In addition, we found that
LPS-induced suppression of SMIT mRNA expression was
completely restored by the addition of allopurinol
(Figure 5c). In contrast, LPS-induced IL-6 production
by macrophages was nearly completely recovered after the
addition of rotenone and myxothiazol, which are inhibitors
of mitochondrial complex-dependent ROS (Figure 5d).
Figure 2 Mutual suppression of NFAT5-governed gene expression by cotreatment with hypertonic stimuli and LPS. (a) Reduction in high
salt-induced increases in AR, BGT1 and SMIT expression by pretreatment with LPS. RAW 264.7 macrophages were preconditioned with
LPS (5mgml1) for 4h and then costimulated with NaCl (90mM) for 4h, or were stimulated first with NaCl for 4h and then cotreated
with LPS for an additional 4h. The mRNA expression levels of AR, BGT1 and SMIT were assessed by real-time PCR. Fold inductions
were calculated using the 2DDCt method. The data are expressed as the mean±s.d. of three independent experiments. *Po0.01.
(b) Suppression of LPS-triggered IL-6 expression by cotreatment with NaCl. IL-6 expression levels were determined by enzyme-linked
immunosorbent assay (left panel) and real-time PCR analysis (right panel). *Po0.01. (c) Hypertonic regulation of IL-6 promoter activity.
RAW 264.7 cells were stimulated with LPS in the presence or absence of NaCl (90mM) for 24h and were subsequently subjected to flow
cytometry analysis of IL-6 promoter activity. *Po0.01.
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Figure 4 ROS regulate NFAT5 activity in a context-dependent manner. (a) Time kinetics of ROS production by RAW 264.7 macrophages
stimulated with LPS or NaCl. ROS expression was determined by flow cytometry using an ROS probe (DCFH-DA (2’,7’-dichlorofluorescein
diacetate)). A representative histogram is shown on the left. The data on the right show the mean±s.d. of three independent experiments
and are expressed as normalized mean fluorescence intensity (MFI) relative to the MFI determined 24h after stimulation with 5mgml1
LPS (set as 100%). *Po0.01 versus NaCl stimulation (90mM). (b) Effects of LPS on high NaCl-induced ROS production by
macrophages. ROS levels were determined 6h after stimulation with 5mgml1 LPS in the presence or absence of 90mM NaCl.
(c) Suppression of high salt-induced NFAT5 activity by myxothiazol (MTZ), a mitochondrial ROS inhibitor, but not by allopurinol (Allo).
ROS scavengers, including Allo (1mM) and MTZ (10mM), were added to RAW 264.7 macrophages 1h before stimulation with NaCl
(90mM) or LPS (5mgml1). NFAT5-dependent reporter activity was then determined by flow cytometry. Representative histograms are
shown on the left. The bar graph shows the mean±s.d. of three independent experiments.
Figure 3 Mannitol induces NFAT5 activity but reduces LPS-induced IL-6 production. (a and b) Dose-dependent increases in NFAT5
reporter activity after treatment with mannitol. Mannitol (100, 200 and 400mM) was added to RAW 264.7 macrophages harboring the
NFAT5 reporter gene for 24h. The bar graph in b shows the mean±s.d. of three independent experiments. (c) Suppression of LPS-
triggered IL-6 production by cotreatment with mannitol. RAW 264.7 macrophages were stimulated with LPS (5mgml1) for 24h in the
presence of mannitol. IL-6 levels in the supernatant were determined by enzyme-linked immunosorbent assay. *Po0.01. The degree of
cell viability was assessed by an MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay and presented as the
percentage of the cell viability of treated samples to the viability of control untreated cells.
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Collectively, these results suggest that the reciprocal inhibition
of LPS and NaCl is achieved via xanthine oxidase-derived ROS
and mitochondrial complex I-dependent ROS, respectively.
We and others have demonstrated that NFAT5 can directly
bind to the IL-6 promoter and that this binding is enhanced by
LPS stimulation.9,16 In this study we used a chromatin
immunoprecipitation assay with an anti-NFAT5 antibody to
confirm the LPS-induced binding of NFAT5 to the IL-6
promoter (base pairs 938 to 11 relative to the start
codon of the IL-6 gene) (Figure 6a). We then tested whether
ROS directly modulated the interaction of NFAT5 with the IL-
6 promoter. As observed in Figure 6b, allopurinol, but not
Figure 5 ROS control LPS- and high salt-induced suppression of NFAT5 target genes. (a and b) ROS dependency of NFAT5 target gene
expression induced by LPS or high salt. The mRNA expression of AR, SMIT, IL-6 and NOS2 was determined by real-time PCR analysis
4h after stimulation with NaCl or LPS. The data are the mean±s.d. of three independent experiments. *Po0.05 versus NaCl (A) or LPS
alone (B). (c and d) ROS inhibitors restore SMIT, IL-6 and MCP-1 expression after combined treatment with high salt and LPS. RAW
264.7 macrophages were pretreated with various concentrations of allopurinol (Allo), rotenone (Ro), or myxothiazol (MTZ) for 1h and then
stimulated with LPS (5mgml1) and NaCl (90mM) for 4 h. IL-6 and MCP-1 concentrations in the culture supernatants were assessed by
enzyme-linked immunosorbent assay. SMIT mRNA expression was determined by real-time PCR. *Po0.01. The degree of cell viability
was assessed by an MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay and presented as the percentage of the cell
viability of treated samples to the viability of control untreated cells.
Figure 6 Rotenone restores the high salt-induced suppression of NFAT5 binding to the IL-6 promoter. (a) Chromatin immunoprecipitation
(ChIP) assay for the NFAT5 binding site within the IL-6 promoter. RAW 264.7 macrophages were stimulated with LPS (5mgml1) for
10h. DNA isolated from anti-NFAT5 precipitation complexes was amplified by PCR using specific primers for the promoter or exon
regions of IL-6. The exon region of the IL-6 gene was used as a negative control. (b) RAW 264.7 macrophages were pretreated with
allopurinol (Allo; 1mM) or rotenone (Ro; 10mM) for 1h, stimulated with LPS (5mgml1) and NaCl (90mM) for 10h, and then subjected
to the ChIP assay. The PCR band densities were normalized relative to the input signals and quantified using ImageJ software (top panel).
A representative of three independent experiments is shown. IP, immunoprecipitation.
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rotenone, completely blocked NFAT5 binding to the IL-6
promoter. In addition, cotreatment with NaCl reduced NFAT5
binding to the IL-6 promoter in RAW 264.7 macrophages, a
trend that was completely reversed by the addition of
rotenone. These results suggest that ROS that are potentially
mitochondrially derived inhibit NFAT5 binding to the IL-6
promoter, which mediates the high salt-induced suppression of
IL-6 production.
We next tested whether the reciprocal inhibition of NFAT5
target genes could be reproduced using hyperosmolar stimuli
and whether this inhibition could be accomplished in other
cell types. As observed in Supplementary Figure 1a, hyper-
osmolar mannitol dose-dependently inhibited IL-6 production
by RAW 264.7 macrophages, and this production was nearly
completely restored by cotreatment with rotenone. Moreover,
in renal tubular epithelial cells (TCMK-1 cells), LPS-induced
IL-6 production was markedly reduced by the addition of LPS
(Supplementary Figures 1b and c), whereas a high salt-induced
increase in SMIT mRNA expression was only partially
blocked by the addition of LPS (Supplementary Figure 1d).
Combined treatment, with the addition of rotenone, dose-
dependently recovered the high salt suppression of LPS-
induced IL-6 production, although this effect was modest
(Supplementary Figures 1b and c). Together, these results
suggest that the context-dependent inhibition of NFAT5
activation and its dependency on ROS occur in multiple cell
types, although to different extents, depending on the stimulus
and cell type.
Context-dependent inhibition of NFAT5 target gene
expression in vivo
We sought to confirm the in vitro findings of the context-
dependent inhibition of NFAT5 target gene expression in the
spleen and kidney of mice treated with LPS and high salt. As
shown in Figure 7a, the administration of hypertonic saline,
but not isotonic saline, suppressed LPS-induced IL-6 mRNA
expression in the mouse spleen. In addition, the kidney cells of
the mice cotreated with NaCl and LPS displayed a significant
decrease in the expression of genes typically induced by high
salt, such as SMIT and AR (Figures 7b and c). To summarize,
we demonstrated that LPS and NaCl both mediated NFAT5
activation via ROS, but reciprocally suppressed the expression
of NFAT5 downstream genes, including IL-6, AR and SMIT,
both in vitro and in vivo (Figure 7d).
DISCUSSION
The most widely observed method of expanding transcrip-
tional regulation is by acquiring a new and distinct function
that places the transcriptional machinery within a distinct
signaling pathway.11 In fact, many transcription factors have
been shown to perform a variety of functions, depending on
the context of the cellular environment.23 For example, CREB
Figure 7 In vivo evidence for the suppression of NFAT5-governed genes by cotreatment with high salt and LPS. (a) High salt-induced
suppression of IL-6 mRNA expression in the spleen. LPS (10mgkg1) was injected intraperitoneally into mice for 7h after challenging
the animals with hypertonic saline (HS; 11.3% HS, 25cckg1) or normal saline (NS; 0.9% NS, 25cckg1). mRNA expression of IL-6
in the spleen was analyzed by real-time PCR. *Po0.01. (b and c) LPS-mediated regulation of tonicity-responsive genes in the kidney.
Under the same conditions as in a, the mRNA expression of IL-6, SMIT and AR in the kidney cells was analyzed by real-time PCR.
*Po0.01. (d) Hypothetical model depicting the role of xanthine oxidase-derived ROS in the context-dependent activation of NFAT5,
leading to IL-6 production upon TLR-4 ligation. ROS (XO), xanthine oxidase-derived ROS; ROS (M), mitochondrially generated ROS.
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and Tlx3 participate in cellular homeostasis and differentiation
by executing context-dependent transcriptional regulation
according to the nature of the stimulus.10,12 In this study we
found that high salt and TLR ligation activate distinct sets of
downstream target genes in RAW 264.7 macrophages in an
NFAT5-dependent manner. Although ROS are essential for
this phenomenon, their sources differ depending on context:
mitochondria for high salt and xanthine oxidase for TLRs.
These two pathways are mutually suppressive both in vitro and
in vivo. Moreover, ROS regulate the context-dependent
inhibition of NFAT5 target gene expression by high salt or
TLR activation. Specifically, high salt-induced suppression of
IL-6 production is mediated through the ROS-induced
inhibition of NFAT5 binding to the IL-6 promoter. These
data provide intriguing evidence for the acquisition of context
dependency.
ROS are generated by one of three mechanisms: (1) a
xanthine oxidase-dependent, (2) a mitochondrial complex-
dependent, or (3) an NADPH oxidase-dependent pathway.24
There are differences in the properties of each ROS type, with
previous studies suggesting that whereas mitochondrially
generated ROS are associated with the progression of heart
failure, ROS derived from xanthine oxidase are involved in
ischemic reperfusion and endothelial dysfunction.25,26 We have
also demonstrated that xanthine oxidase-induced ROS, but
not mitochondria-derived ROS, have a key role in the
progression of inflammatory arthritis by activating NFAT5.16
Demonstrating differences in the biochemical characteristics
of mitochondria-derived and xanthine oxidase-induced ROS is
a technically challenging process, mainly due to these species’
extremely short half-lives. Our results, however, may help to
more easily distinguish between these properties. We presumed
that the major source of ROS was likely different under
hypertonic and nonhypertonic inflammatory conditions. We
then observed that NFAT5-dependent IL-6 production was
higher in RAW 264.7 macrophages treated with LPS alone than
in cells cotreated with LPS and NaCl. In addition, decreased
IL-6 promoter enrichment in cotreated cells was restored by
pretreatment with the mitochondrial complex inhibitor rote-
none. Conversely, LPS-induced suppression of SMIT, a toni-
city-inducible gene, was completely reversed by xanthine
oxidase inhibition. ROS from different sources may act directly
on NFAT5 or act indirectly by initiating the differential
activation of other signaling molecules within the cells. In
fact, individual ROS with distinct chemical properties have
been shown to be involved in specific signaling,27 displaying
significant diversity in the types of affected transcription
factors.28
Although it was previously established that hypertonic
solution injections alleviate inflammatory responses and
improve sepsis,29,30 it was unclear how this effect was
achieved. In the present study we demonstrated that
pretreatment of RAW 264.7 macrophages with high salt or
hyperosmolar mannitol blocked LPS-induced IL-6 production,
which was recovered by cotreatment with rotenone. These
results indicate that hypertonic regulation of the
proinflammatory response is mediated by the context-
dependent activation of NFAT5 target genes through
xanthine oxidase- and/or mitochondrial complex I-derived
ROS. Of note, when LPS was added to the macrophages in the
presence of NaCl, NFAT5 and ROS production were not
suppressed (Figures 1a and 4b). In addition, the time kinetics
of the increases in NFAT5 and ROS did not differ between cells
stimulated with LPS or NaCl (Figure 4a, data not shown).
These results suggest that the quantitative changes in and time
kinetics of NFAT5 and ROS are irrelevant to the context-
dependent inhibition of IL-6 production and to the proin-
flammatory response induced by TLR ligation.
Although the context-dependent inhibition of NFAT5
activation and its dependency on ROS occur in multiple cell
types, the extent seems to differ depending on the stimulus
and cell type (Supplementary Figure 1). Moreover, several
NFAT5 target genes were not completely dependent on ROS in
RAW 264.7 macrophages (for example, AR expression in
Figure 5a), indicating that in addition to ROS, other products,
including proinflammatory cytokines and prostaglandins, may
be directly involved in NFAT5 induction and the subsequent
activation of NFAT5 target genes. In support of this notion,
prostaglandin E2, which is known to be rapidly induced by
LPS and high salt, stimulates the expression of osmoprotective
genes, such as AR and SMIT, in MDCK cells and promotes
survival under hypertonic conditions.31 Further study will be
required to clarify this issue.
The context dependency of NFAT5 demonstrated in the
present study has several potential clinical applications. It is
well established that infections frequently occurring under
hypertonic or hyperosmolar conditions, as observed in dehy-
dration and diabetic hyperglycemia, tend to facilitate damage
to the kidneys and other organs. The pathophysiology of this
organ damage, however, remains unknown. We found that the
induction of osmoprotective gene expression (for example, AR
and SMIT) by high salt in the kidney was significantly
hampered by TLR4 stimulation both in vitro and in vivo. This
finding suggests that damage to the kidney tissues may be
caused by the context-dependent inhibition of the osmopro-
tective action of NFAT5. This notion is supported by earlier
reports showing that the inhibition of AR and SMITexpression
causes renal injury in animal models.32,33 Thus, ROS inhibitors
may be potential therapeutic agents for preventing or treating
renal injury under hypertonic or hyperosmolar conditions that
are often observed in cases of bacterial infection.
In summary, we identified a novel context-dependent
suppression of NFAT5 target gene expression in RAW 264.7
macrophages, which may facilitate NFAT5-induced activation
of proinflammatory or hypertonic responses. Although LPS
and NaCl both use NFAT5 as a core transcription factor, these
stimuli mutually inhibit distinct sets of NFAT5 target genes via
ROS derived from xanthine oxidase and the mitochondria,
respectively. Our data provide intriguing evidence for cell-
acquired context dependency and functional diversity via a
single transcription factor. In addition, our findings present
the possibility of developing ROS inhibitors as therapeutic
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NH Kim et al
9
Experimental & Molecular Medicine
agents for treating NFAT5-dependent renal injury and chronic
inflammatory diseases, including diabetic nephropathy, ather-
osclerosis, hypertension and chronic arthritis.16
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